Guardant Health Inc annual ebitda for fiscal 2025 was -$374 million, an increase of 4.1% from -$390 million in fiscal 2024. All figures are reported results from public filings — no estimates or projections.
| EBITDA (annual) | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EBITDA | — | ($374M) | ($390M) | ($433M) | ($615M) | ($360M) | ($225M) | ($55M) | ($76M) | ($75M) | ($39M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| EBITDA (quarterly) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|---|
| EBITDA | — | ($101M) | ($119M) | ($82M) | ($89M) | ($84M) | ($99M) | ($96M) | ($91M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More GH metrics: Revenue · Gross Profit · Operating Income · Net Income · EPS · Free Cash Flow · Shares Outstanding
All GH financial statements → Interactive GH charts →
About TickerBase · Data methodology & sources · Privacy · Terms